Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.
Adv Ther. 2023 Aug;40(8):3559-3573. doi: 10.1007/s12325-023-02534-w. Epub 2023 Jun 18.
Adv Ther. 2023.
PMID: 37330927
Free PMC article.
Clinical Trial.
Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials.
Tanihara H, Yamamoto T, Aihara M, Kawakita K, Kojima S, Kanazawa M, Nojima T, Suganami H; K-232 Clinical Study Group.
Tanihara H, et al.
Am J Ophthalmol. 2023 Apr;248:35-44. doi: 10.1016/j.ajo.2022.11.017. Epub 2022 Nov 21.
Am J Ophthalmol. 2023.
PMID: 36410471
Free article.
Clinical Trial.
Item in Clipboard
Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study.
Tanihara H, Yamamoto T, Aihara M, Koizumi N, Fukushima A, Kawakita K, Kojima S, Nakamura T, Suganami H; K-232 Clinical Study Group.
Tanihara H, et al.
Graefes Arch Clin Exp Ophthalmol. 2024 Mar 2. doi: 10.1007/s00417-024-06388-y. Online ahead of print.
Graefes Arch Clin Exp Ophthalmol. 2024.
PMID: 38430227
Item in Clipboard
Cite
Cite